Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-002240
Filing Date
2025-04-01
Accepted
2025-04-01 21:13:36
Documents
1
Period of Report
2025-03-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5736
  Complete submission text file 0001641172-25-002240.txt   7308
Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Lewis-Hall Freda C (Reporting) CIK: 0001437909 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 25801731

Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)